CRYO-CELL International, Inc. - CCEL - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

CRYO-CELL International, Inc. - SIC # 8099

Ticker	Exchange	SIC #	Website	Latest Ticker
CCEL	Over the counter	8099	http://www.cryo-cell.com	2.19 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for CRYO-CELL International, Inc. CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers - May 6th, 2013 8:11 am CRYO CELL INTERNATIONAL INC Financials - Apr 19th, 2013 11:04 am CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report - Apr 15th, 2013 8:03 am CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a - Apr 5th, 2013 8:09 am Cryo-Cell Reports First Quarter 2013 Results - Apr 5th, 2013 6:00 am Cryo-Cell International Affiliate Earns Patent for Processing Umbilical Cord Blood for Therapeutic Use in Treating Neurodegenerative Diseases and Spinal Cord and Brain Injuries - Mar 15th, 2013 4:00 am CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a - Mar 4th, 2013 2:20 pm Cryo-Cell Reports Financial Results for Fiscal 2012 - Feb 28th, 2013 3:30 pm CRYO CELL INTERNATIONAL INC Files SEC form 10-K, Annual Report - Feb 28th, 2013 3:18 pm Second Stem Cell Expert from Harvard’s Dana-Farber Cancer Institute Joins Cryo-Cell International - Nov 13th, 2012 10:07 am Cryo-Cell loss shrinks, revenue gains - Oct 16th, 2012 7:39 am CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a - Oct 15th, 2012 3:22 pm CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report - Oct 15th, 2012 2:51 pm Proxy fight impacts bottom line at Cryo-Cell - Jul 18th, 2012 9:49 am CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a - Jul 18th, 2012 4:02 am CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report - Jul 16th, 2012 3:16 pm Portnoys survive Cryo-Cell proxy fight - Jul 16th, 2012 4:32 am CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statem - Jul 13th, 2012 12:37 pm CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - Jul 5th, 2012 3:16 pm Taking sides in the Cryo-Cell fight - Jul 5th, 2012 12:48 pm View All Current Headlines >>